Drawing for BIZURAN

USPTO serial 79247105

BIZURAN

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
—
Examiner
LAVACHE, LINDA M
Law office
TMEG LAW OFFICE 106 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BIZURAN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Medicines for the treatment of age-related macular degenerationSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 13, 2019DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Jul 12, 2019DETHDEATH OF INTERNATIONAL REGISTRATION—
Mar 16, 2019RFNTREFUSAL PROCESSED BY IB—
Feb 26, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 26, 2019RFRRREFUSAL PROCESSED BY MPU—
Feb 15, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 14, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 7, 2019DOCKASSIGNED TO EXAMINER—
Dec 18, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 13, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 6, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance